These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 3265130
21. Activity of cephalosporin antibiotics against Haemophilus influenzae. Philpott-Howard J, Williams JD. Scand J Infect Dis Suppl; 1983; 39():109-11. PubMed ID: 6606223 [Abstract] [Full Text] [Related]
25. Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins. García-de-Lomas J, Lerma M, Cebrián L, Juan-Bañón JL, Coronel P, Giménez MJ, Aguilar L. Int J Antimicrob Agents; 2007 Aug; 30(2):190-2. PubMed ID: 17459665 [No Abstract] [Full Text] [Related]
26. Effect of extended-spectrum beta-lactamases on the susceptibility of Haemophilus influenzae to cephalosporins. Tristram SG. J Antimicrob Chemother; 2003 Jan; 51(1):39-43. PubMed ID: 12493785 [Abstract] [Full Text] [Related]
27. Evaluation of Hemophilus type B systemic isolates for beta-lactamase and non-beta-lactamase mediated ampicillin resistance and for susceptibility to other antimicrobial agents. Woolfrey BF, Lally RT, Ederer MN. Am J Clin Pathol; 1987 Sep; 88(3):361-5. PubMed ID: 3498359 [Abstract] [Full Text] [Related]
28. Antibiotic susceptibility of invasive Haemophilus influenzae type b isolates in Denmark in 1988 and 1989. Kristensen K, Mortensen I. Scand J Infect Dis; 1991 Sep; 23(3):337-40. PubMed ID: 1882199 [Abstract] [Full Text] [Related]
30. In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains. Miyazaki S, Fujikawa T, Kanazawa K, Yamaguchi K. J Antimicrob Chemother; 2001 Nov; 48(5):723-6. PubMed ID: 11679563 [Abstract] [Full Text] [Related]
31. In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b. LiPuma JJ, Daley B, Stull TL. J Antimicrob Chemother; 1990 Apr; 25(4):535-9. PubMed ID: 2141018 [Abstract] [Full Text] [Related]
32. Evaluation of disk diffusion methods to detect low-level β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Nørskov-Lauritsen N, Ridderberg W, Erikstrup LT, Fuursted K. APMIS; 2011 Jun; 119(6):385-92. PubMed ID: 21569097 [Abstract] [Full Text] [Related]
35. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks. Zerva L, Biedenbach DJ, Jones RN. J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892 [Abstract] [Full Text] [Related]
36. Chloramphenicol kills Haemophilus influenzae more rapidly than does ampicillin or cefamandole. Schauf V, Green DC, van der Stuyf L, Riff L. Antimicrob Agents Chemother; 1983 Mar; 23(3):364-8. PubMed ID: 6601927 [Abstract] [Full Text] [Related]
37. Growth curves, microscopic morphology, and subcultures of beta-lactamase-positive and -negative Haemophilus influenzae under the influence of ampicillin and cefamandole. Yourassowsky E, Van Der Linden MP, Lismont MJ. Antimicrob Agents Chemother; 1979 Mar; 15(3):325-31. PubMed ID: 313751 [Abstract] [Full Text] [Related]
38. Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae. Sykes RB, Griffiths A, Ryan DM. Antimicrob Agents Chemother; 1977 Apr; 11(4):599-604. PubMed ID: 301007 [Abstract] [Full Text] [Related]